MARKET

CARL

CARL

CARLSMED INC
NASDAQ
11.80
-0.20
-1.67%
Opening 09:30 03/09 EDT
OPEN
11.80
PREV CLOSE
12.00
HIGH
12.27
LOW
11.80
VOLUME
3.88K
TURNOVER
--
52 WEEK HIGH
17.19
52 WEEK LOW
10.65
MARKET CAP
315.44M
P/E (TTM)
-2.7768
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CARL last week (0302-0306)?
Weekly Report · 9h ago
Carlsmed CEO and President Michael Cordonnier Disposes of Common Shares
Reuters · 4d ago
Weekly Report: what happened at CARL last week (0223-0227)?
Weekly Report · 03/02 09:07
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives
Simply Wall St · 02/27 00:37
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL)
TipRanks · 02/26 13:01
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sarepta Therapeutics (SRPT), Insmed (INSM) and Carlsmed, Inc. (CARL)
TipRanks · 02/26 12:50
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Carlsmed, Inc. (CARL) and Agilent (A)
TipRanks · 02/26 11:41
Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M
Seeking Alpha · 02/26 06:59
More
About CARL
Carlsmed, Inc. is a commercial-stage medical technology company providing AI-enabled personalized spine surgery solutions. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.

Webull offers Carlsmed, Inc. stock information, including NASDAQ: CARL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CARL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CARL stock methods without spending real money on the virtual paper trading platform.